Concepedia

Tianyuan Xie

TX

3

Publications

53

Citations

3

H-Index

2023

Active since

Affiliations

China Pharmaceutical University(Current)

Tianyuan Xie is an author at China Pharmaceutical University specializing in drug discovery, tumor biology, and medicinal chemistry.

Top concepts

Publications per year

2023–2024

3

Publications

3

Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer

Lufeng Zheng, Yuxin Zhang, Shuang Mei et al. · Journal of Medicinal Chemistry · 2024 · 22 citations · Full text

Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation

Lufeng Zheng, Yunting Zou, Tianyuan Xie et al. · Journal of Medicinal Chemistry · 2023 · 18 citations

, , +21

A positive TGF‐β/<i>miR‐9</i> regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer

Yichen Liu, Ying Chen, Qiong Zhao et al. · British Journal of Pharmacology · 2023 · 13 citations · Full text

Rows per page

1–3 of 3